Skip to main content

Posts

Fukushima Thyroid Examination December 2016: 145 Thyroid Cancer Cases Confirmed (101 in the First Round and 44 in the Second Round)

145 Thyroid cancer cases confirmed in Fukushima as of September 30, 2016--101 in the first round and 44 in the second round (Total of 183 cases including suspected cancer cases--115 in the first round and 68 in the second round).

On December 27, 2016, the 25th Oversight Committee for Fukushima Health Management Survey convened in Fukushima City, Fukushima Prefecture. Among other information, the Oversight Committee released the latest results (as of September 30, 2016) of thesecond and third rounds of the Thyroid Ultrasound Examination (TUE). Official English translation of the results is posted here. The narrative below presents basic facts from the new data in perspective, including information covered during the committee meeting and the subsequent press conference.

Overview
As of September 30, 2016, there are 9 more cases with cancer or suspicion of cancer from the second round, making a grand total of 183 (184 including the single case of post-surgically confirmed benign nodule) for…

Clinicopathological Findings of Fukushima Thyroid Cancer Cases: October 2016

*The Japanese version of this post can be found here.

On September 26-27, 2016, the "5th International Expert Symposium in Fukushima on Radiation and Health: Chernobyl+30, Fukushima+5: Lessons and Solutions for Fukushima’s Thyroid Question" was held in Fukushima City. The symposium was organized by the Nippon Foundation, co-organized by Fukushima Medical University, Nagasaki University, and Hiroshima University, and supported by Fukushima Prefecture, Japan Medical Association, Japan Nursing Association, and Japan Pharmaceutical Association. Program PDF can be viewed here. Information on previous symposia can be found on the following web pages: 1st symposium, 2nd symposium, 3rd symposium, and 4th symposium.

The program featured the usual suspects from the pro-nuclear camp as some of the presenters who informed the audience that "Fukushima is different from Chernobyl" and emphasized the risk of overdiagnosis from cancer screening. This post focuses on clinical informa…